EGFR/HER2 Kinase Inhibitor TAK-285

An orally bioavailable, small molecule and dual kinase inhibitor of human epidermal growth factor receptors 1 (EGFR/ErbB1) and 2 (HER2/ErbB2), with potential antineoplastic activity. EGFR/HER2 kinase inhibitor TAK-285 binds to and inhibits EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing tumor cells that are resistant to trastuzumab. EGFR and HER2, receptor tyrosine kinases overexpressed in a variety of tumor cell types, play major roles in tumor cell proliferation and tumor vascularization. In addition, TAK-285 appears to pass the blood brain barrier (BBB) and does not appear to be a substrate for efflux pumps. (NCI Thesaurus)

YOU MAY ALSO LIKE

EGFR/HER2 Inhibitor AV-412

A second-generation, orally bioavailable dual kinase inhibitor with potential antineoplastic activity. EGFR/HER2 inhibitor AV-412 binds to and inhibits the epidermal growth factor…

EGFR-TKI Sensitizing Mutation

A molecular genetic abnormality indicating the presence of a sensitizing mutation in the epidermal growth factor receptor-tyrosine kinase inhibitor domain.

EGFR-TKI Resistant Mutation

A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations…

EGFR wt Allele

Human EGFR wild-type allele is located within 7p12 and is approximately 188 kb in length. This allele, which encodes epidermal growth factor…

EGFR tyrosine kinase inhibitor

A substance that blocks the activity of a protein called epidermal growth factor receptor (EGFR). EGFR is found on the surface of…

EGFR Protein Variant

A variation in the amino acid sequence for the epidermal growth factor receptor protein.